CapsoVision stockholders re-elect three Class I directors, ratify Baker Tilly as auditor

CapsoVision, Inc

Joanne Imperial, M.D. re-elected with 32,060,734 votes for and 70,447 withheld (2,244,596 broker non-votes).
Wen-Herng (Henry) King re-elected with 32,065,119 votes for and 66,062 withheld.
Michele Harari re-elected with 32,066,645 votes for and 64,536 withheld.
Ratification of Baker Tilly US, LLP as independent auditor for FY 2026 approved: 34,321,524 for, 154 against, 54,099 abstentions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CapsoVision, Inc shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year at the 2026-06-11 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Proposal #2 for the ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was approved.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CapsoVision, Inc shareholders approved Election of Class I Directors at the 2026-06-11 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Proposal #1 for the election (re-election) of the Class I Directors. The nominees listed below were re-elected at the Meeting to serve as Class I Directors of the Company until the Company's 2029 annual meeting of stockholders.

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CapsoVision, Inc filing history →

Source: SEC EDGAR

accession 0001378325-26-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.